Biosimilars: Market Access & Adoption
This session focuses on the strategic and policy-driven elements that influence global biosimilar adoption and market integration. Topics include healthcare system readiness, pricing models, payer frameworks, and reimbursement pathways that shape biosimilar uptake. Real-world case studies will highlight successful biosimilar launches, market access hurdles, and the regulatory-economic balance needed for sustainable adoption. Participants will explore regional dynamics in biosimilar penetration across Europe, North America, and emerging economies, and assess stakeholder education as a critical driver for prescriber and patient acceptance. Key insights into tendering processes, procurement strategies, and policy incentives will be discussed, along with practical approaches to overcome skepticism and improve substitution rates. The session will be particularly beneficial for market strategists, policy experts, payers, and regulatory professionals aiming to bridge the gap between biosimilar development and accessible patient care.